Indo National Ltd

Indo National Board Meeting Date

Indo National's board meets on 12 November 2026 to approve unaudited half-year results. Insider trading window stays closed until 48 hours after results.

Indo National Acquisition Worth ₹0.25 Cr

Indo National invested Rs.0.25 Crore in 178 shares of Medcuore Medical Solutions, raising its stake to 63.46%. The acquisition targets growth in air monitoring and purifier business.

Value

₹0.25 Cr

Indo National Other Announcement

Indo National Ltd has filed its quarterly shareholding pattern for the quarter ended September 30, 2026. This is a routine regulatory disclosure of shareholding distribution.

Indo National Business Update

Indo-National Ltd approved a Memorandum of Agreement to cease distribution arrangements with Radiohms Agencies, involving a net payment of ₹2.36 Crore for settling inter-se payables.

Value

₹2.36 Cr

Indo National Acquisition Worth ₹3.91 Cr

Indo National Limited has invested ₹3.91 Crore to acquire a further 0.30% stake in Axial Aero Private Limited, bringing its total holding to 7.97%.

Value

₹3.91 Cr

Indo National Acquisition Worth ₹0.5 Cr

Indo National acquired an additional 0.79% stake in Medcuore Medical Solutions for ₹0.50 Crore, taking its total shareholding in the subsidiary to 63.07%.

Value

₹0.50 Cr

Execution

Upto FY 2027-28

Indo National Annual General Meeting

Indo National Ltd held its 53rd Annual General Meeting on September 28, 2026. Shareholders transacted ordinary and special business, including dividend declaration and auditor remuneration approval.

Indo National Annual General Meeting

Indo-National Limited has scheduled its 53rd AGM and book closure from September 22 to 28, 2026. The record date for the dividend payment is September 21, 2026.

Indo National Acquisition Worth ₹3.91 Cr

Indo National Ltd will invest ₹3.91 Crore in Axial Aero Pvt Ltd by subscribing to 35,249 Class C CCPS, increasing its stake to 7.97%.

Value

₹3.91 Cr

Indo National Acquisition Worth ₹0.25 Cr

Indo National Ltd invested Rs. 0.25 Crore to acquire an additional 0.41% stake in Medcuore Medical Solutions. This raises its total holding to 62.28%.

Value

₹0.25 Cr

From

Medcuore Medical Solutions Private Ltd

Execution

Upto FY 2027-28

Indo National Other Announcement

Indo National Limited has informed shareholders with unregistered email addresses about the availability of the FY 2025-26 Annual Report via a website link. This is a routine regulatory compliance filing.

Indo National Annual General Meeting

Indo National Limited will hold its 53rd Annual General Meeting on September 28, 2026. The agenda includes adopting financial statements and declaring a Rs.3.75 per share dividend.

Indo National Annual Report

Indo National Limited submitted its 53rd Annual Report for FY 2025-26. The company convened its Annual General Meeting for September 28, 2026, via video conferencing.

Indo National Acquisition Worth ₹0.5 Cr

Indo National Limited invested Rs. 0.50 Crore to acquire an additional 0.78% stake in Medcuore Medical Solutions Private Ltd. This increases its total shareholding to 61.87%.

Value

₹0.50 Cr

Execution

Upto FY 2027-28

Indo National Management Change

Indo National Limited announced the resignation of Mr. Binu Sekhar from the position of Chief Sales Officer. The resignation is effective from September 1, 2026.

Indo National Q1 FY27 Results: Net Profit ₹2 Cr, Up 81.8% YoY

Indo National Ltd reported revenue from operations of ₹116.1 Cr (-2.8% YoY) and net profit of ₹2 Cr (+81.8% YoY) for Q1 FY27.

Key figure

Net profit ₹2 Cr · +81.8% YoY

Indo National Board Meeting Date

Indo National Ltd has scheduled a board meeting on August 14, 2026, to consider and approve the unaudited financial results for the quarter ended June 30, 2026.

Indo National Merger & Restructuring Worth ₹35 Cr

Indo National Ltd invested ₹34.99 Crore to acquire a 31.82% stake in Aidin Technologies Private Limited. The acquisition expands the company's presence in defence electronics.

Value

₹35.00 Cr

Indo National Merger & Restructuring Worth ₹0.49 Cr

Indo-National Limited is acquiring a stake in Medcuore Medical Solutions Private Limited for ₹0.49 Crore. The acquisition aims to facilitate business growth in air monitoring systems.

Value

₹0.49 Cr

Execution

Upto FY 2027-28

Indo National Merger & Restructuring Worth ₹0.5 Cr

Indo National Ltd invested Rs. 49.94 Lakh in Medcuore Medical Solutions Private Limited. This subscription of equity shares increases the company's stake to 61.09%.

Value

₹0.50 Cr

Execution

Upto FY 2027-28

Indo National Merger & Restructuring Worth ₹0.74 Cr

Indo-National Limited is acquiring an additional stake in Medcuore Medical Solutions for Rs. 0.74 Crore. This cash transaction aims to expand business into air monitoring systems.

Value

₹0.74 Cr

Execution

Upto FY 2027-28

Indo National Merger & Restructuring Worth ₹0.75 Cr

Indo National invested Rs. 0.75 Crore to acquire an additional 1.18% stake in Medcuore Medical Solutions. Total shareholding increases to 60.34% to facilitate business growth.

Value

₹0.75 Cr

Execution

Upto FY 2027-28

Indo National Acquisition Worth ₹0.99 Cr

Indo-National Limited is acquiring additional equity in Medcuore Medical Solutions for ₹0.99 Crore. This strategic cash investment aims to facilitate business growth in air monitoring systems.

Value

₹0.99 Cr

Execution

Upto FY 2027-28

Indo National Merger & Restructuring Worth ₹1 Cr

Indo National Limited invested ₹1.00 Crore to acquire an additional 1.68% stake in its subsidiary MMSPL. Total shareholding increased to 59.16% to support business expansion.

Value

₹1.00 Cr

Execution

Upto FY 2027-28

Indo National Q4 FY26 Results: Net Loss of ₹21 Cr

Indo National Ltd reported revenue from operations of ₹107.1 Cr (+10.3% YoY) and a net loss of ₹21 Cr for Q4 FY26.

Key figure

Net loss ₹21 Cr

Indo National Acquisition Worth ₹0.8 Cr

Indo National Limited invested ₹0.80 Crore to acquire an additional 2.69% stake in Medcuore Medical Solutions. This increases total ownership to 57.48% in the subsidiary.

Value

₹0.80 Cr

Execution

Upto FY 2027-28

Indo National Board Meeting Date

Indo-National Limited has scheduled a board meeting for May 15, 2026. The board will consider audited standalone and consolidated financial results for the year ended March 2026 and recommend a final dividend. The trading window remains closed until May 17, 2026.

Indo National Board Meeting Date

Indo National Ltd has scheduled a Board of Directors meeting on May 15, 2026. The board will consider and approve audited standalone and consolidated financial results for the quarter and year ended March 31, 2026, and recommend a dividend.

Indo National Acquisition Worth ₹78.05 Cr

Indo-National Limited is acquiring at least 51% of Aidin Technologies Private Limited for ₹78.05 Crore in two tranches. The acquisition allows the company to enter the sunrise defense and aerospace electronics sector, specifically targeting the ₹25,000 Crore defense electronics market to drive revenue growth and profitability.

Value

₹78.05 Cr

Execution

Tranche 1: June 2026; Tranche 2: 12 months after Tranche 1

Indo National Acquisition Worth ₹78.05 Cr

Indo-National Limited is acquiring a 51% stake in Aidin Technologies Private Limited for ₹78.05 Crore. The transaction will be executed in two tranches to expand the company's presence into high-growth sectors like defense, aerospace, and satellite technology.

Value

₹78.05 Cr

Execution

Tranche 1 by June 2026; Tranche 2 within 12 months of Tranche 1.